AiViva BioPharma
PrivateLast Round
Crowdfunding
Dec 14, 2022
Est. Valuation
$49.79M
Total Funding Raised
$31.03M
Company Overview
AiViva BioPharma operates in Healthcare & Life Sciences and is based in Costa Mesa, California. Its latest recorded funding round was a Crowdfunding round in December 2022.
AiViva BioPharma is a biotechnology company that develops novel pharmaceutical products and focal therapies for dermatology, ophthalmology, oncology, and urology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AiViva BioPharma Comparables
Compare AiViva BioPharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AmacaThera | 76% | |
| Ripple Therapeutics | 76% | |
| Re-Vana Therapeutics | 73% |
For institutional investors. Book with your work email.
AiViva BioPharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Dec 14, 2022 | ||||
| Series A | Feb 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AiViva BioPharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartEngine Crowdfunding | Crowdfunding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
Monthly visitors increased 202% MoM.
- Nov 9, 2024
Monthly visitors increased 83% MoM, reaching 1.7K.
For institutional investors. Book with your work email.
AiViva BioPharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AiViva BioPharma's valuation, stock price, and market status.
Is AiViva BioPharma a public or private company?
AiViva BioPharma is a private company.
What is the current stock price of AiViva BioPharma?
AiViva BioPharma is a private company, so its shares have no public market price. Caplight tracks AiViva BioPharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AiViva BioPharma worth (valuation)?
AiViva BioPharma's valuation is estimated at $49.8M based on funding round data.
Can I buy AiViva BioPharma stock?
AiViva BioPharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AiViva BioPharma's last funding round?
AiViva BioPharma's most recent funding round was Crowdfunding on December 14, 2022.
Who are the main investors in AiViva BioPharma?
Key investors in AiViva BioPharma include StartEngine Crowdfunding.
Will AiViva BioPharma IPO soon?
No public IPO plans have been announced for AiViva BioPharma.
How can I track AiViva BioPharma secondary market activity?
Caplight tracks bids, offers, and trades in AiViva BioPharma's shares on secondary markets.